542 related articles for article (PubMed ID: 9458081)
1. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
5. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
7. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of experimental colon cancer by genistein.
Rao CV; Wang CX; Simi B; Lubet R; Kelloff G; Steele V; Reddy BS
Cancer Res; 1997 Sep; 57(17):3717-22. PubMed ID: 9288778
[TBL] [Abstract][Full Text] [Related]
9. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
10. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
[TBL] [Abstract][Full Text] [Related]
11. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
[TBL] [Abstract][Full Text] [Related]
12. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats.
Shih CK; Chiang W; Kuo ML
Food Chem Toxicol; 2004 Aug; 42(8):1339-47. PubMed ID: 15207385
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
Fischer SM; Lo HH; Gordon GB; Seibert K; Kelloff G; Lubet RA; Conti CJ
Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris RE; Alshafie GA; Abou-Issa H; Seibert K
Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K
Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
Kawamori T; Uchiya N; Kitamura T; Ohuchida S; Yamamoto H; Maruyama T; Sugimura T; Wakabayashi K
Anticancer Res; 2001; 21(6A):3865-9. PubMed ID: 11911260
[TBL] [Abstract][Full Text] [Related]
18. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
Rao CV; Desai D; Rivenson A; Simi B; Amin S; Reddy BS
Cancer Res; 1995 Jun; 55(11):2310-5. PubMed ID: 7757981
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.
Rao CV; Rivenson A; Simi B; Reddy BS
Cancer Res; 1995 Jan; 55(2):259-66. PubMed ID: 7812955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
